According to AFR the Imed sale isn’t totally dead, with talks continuing between Permira and EQT. Price apparently is the sticking point. If a sale does happen, then potentially Permira might also look at adding IDX. I like what CAJ is doing with its other acquisitions and new clinics, remain wary of the IDX bid.
According to AFR the Imed sale isn’t totally dead, with talks...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CAJ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.005(1.69%) |
Mkt cap ! $319.8M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.5¢ | 29.8¢ | $687.5K | 2.300M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 113389 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 15460 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| CAJ (ASX) Chart |